Hepatitis A ACIP Vaccine Recommendations
Advisory Committee on Immunization Practices (ACIP)
On This Page
Published in Morbidity and Mortality Weekly Report (MMWR)
The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).
CURRENT Hepatitis A Vaccine Recommendations
- MMWR, July 3, Vol 69, #5
Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
Print version pdf icon[42 pages] - See also:
ARCHIVED Hepatitis A Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
- MMWR, February 15, Vol 68, #6
Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
Print version pdf icon[4 pages] - MMWR, November 2, 2018, Vol 67, #43
Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
Print version pdf icon[5 pages] - MMWR, September 18, 2009, Vol 58, #36
Updated Recommendations from the ACIP for Use of Hepatitis A Vaccine in Close Contacts of Newly Arriving International Adoptees
Print version pdf icon[1.78 MB, 36 pages] - MMWR, October 12, 2007, Vol 56, #40
Notice to Readers: FDA Approval of an Alternate Dosing Schedule for a Combined Hepatitis A and B Vaccine (Twinrix®)
Print version pdf icon[28 pages] - MMWR, October 19, 2007, Vol 56, #41
Update: Prevention of Hepatitis A After Exposure to Hepatitis A Virus and in International Travelers. Updated Recommendations of the ACIP
Print version pdf icon[32 pages] - MMWR, May 19, 2006, Vol 55, #RR-07
Prevention of Hepatitis A Through Active or Passive Immunization
Print version pdf icon[1.18 MB, 30 pages] - MMWR, December 9, 2005, Vol 54, #48
Notice to Readers: FDA Approval of Havrix® (Hepatitis A Vaccine, Inactivated) for Persons Aged 1-18 Years
Print version pdf icon[24 pages] - MMWR, October 14, 2005, Vol 54, #40
Notice To Readers: FDA Approval of VAQTA® (Hepatitis A Vaccine, Inactivated) for Children Aged >1 Year
Print version pdf icon[32 pages] - MMWR, September 21, 2001, Vol 50, #37
Notice to Readers: FDA Approval for a Combined Hepatitis A and B Vaccine
Print version pdf icon[24 pages]
Page last reviewed: November 21, 2014
Content source: National Center for Immunization and Respiratory Diseases